|Videos|July 11, 2018
Considerations for Using Adjuvant Therapy in mRCC
Advertisement
Episodes in this series
Transcript:
Advertisement
Related to this article
TKI-based regimens were associated with higher rates of disease control in metastatic translocation renal cell carcinoma.
Advertisement
Advertisement
Trending on OncLive
1
CLL Treatment Individualization Prompts Changes in Patient Evaluation and Care
2
Japan Approves Subcutaneous Pembrolizumab for All Approved Pembrolizumab Indications
3
FDA Grants Fast Track Designation to LYT-200 in R/R High-Risk MDS
4
Integrating Bispecific Antibodies Into Frontline Therapy for Newly Diagnosed Multiple Myeloma
5